Kyntra Bio Inc.
KYNB | NASDAQ
$4.57
-$0.08 (-1.72%)
At close: Oct 30, 2026, 4:00 PM ET
$4.51
-$0.06 (-1.31%)
Pre-market:
Nov 2, 2026, 7:36 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 47.87M | 50.48M | 113.69M | 155.7M | 171.22M | 678.39M |
Short-Term Investments | 41.11M | n/a | 121.9M | 266.31M | 233.97M | 8.14M |
Long-Term Investments | 20.16M | n/a | 5.29M | 9.41M | 171.62M | 2.97M |
Other Long-Term Assets | 361K | 18.02M | 5.31M | 7.35M | 8.75M | 5.51M |
Receivables | 4.22M | 28.98M | 41.05M | 16.3M | 25.4M | 41.88M |
Inventory | 3.74M | 3.16M | 41.57M | 40.44M | 31.02M | 16.53M |
Other Current Assets | 1.12M | 111.99M | 6.71M | 4.35M | 5.07M | 1.81M |
Total Current Assets | 99.07M | 196.51M | 331.56M | 492.83M | 474.06M | 755.11M |
Property-Plant & Equipment | n/a | n/a | 81.37M | 100.5M | 119.39M | 63.25M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 20.52M | 18.02M | 91.97M | 117.26M | 299.76M | 71.73M |
Total Assets | 119.59M | 214.53M | 423.53M | 610.09M | 773.82M | 826.84M |
Account Payables | 3.75M | 5.06M | 17.96M | 30.76M | 26.1M | 24.79M |
Deferred Revenue | 5.31M | 27.29M | 12.74M | 12.74M | 19.03M | 6.55M |
Short-Term Debt | n/a | n/a | 40K | n/a | n/a | n/a |
Other Current Liabilities | 3.16M | 70.29M | 152.58M | 7.25M | 4.91M | 95.53M |
Total Current Liabilities | 29.24M | 133.31M | 217.67M | 273.56M | 225.5M | 163.19M |
Long-Term Debt | n/a | 73.09M | 89.7M | n/a | n/a | n/a |
Other Long-Term Liabilities | 85.62M | 77.05M | 54.17M | 72.69M | 43.63M | 57.49M |
Total Long-Term Liabilities | 85.88M | 264.85M | 368.06M | 338.01M | 319.21M | 222.2M |
Total Liabilities | 115.12M | 398.16M | 585.73M | 611.57M | 544.71M | 385.39M |
Total Debt | n/a | 73.09M | 170.46M | 89.89M | 99.72M | 39.76M |
Book Value | 4.48M | -183.64M | -162.2M | -1.48M | 229.11M | 441.45M |
Book Value Per Share | 1.11 | -45.89 | -41.67 | -0.40 | 62.02 | 122.82 |
Common Stock | 1.01M | 1.01M | 988K | 942K | 929K | 914K |
Retained Earnings | -1.71B | -1.89B | -1.84B | -1.56B | -1.26B | -974.01M |
Comprehensive Income | -2.18M | -5.73M | -6.88M | -5.72M | -4.16M | -4.5M |
Shareholders Equity | -30.04M | -225.6M | -204.17M | -21.45M | 209.15M | 422.18M |
Total Investments | 61.27M | n/a | 127.19M | 275.72M | 405.59M | 11.12M |
Add to Watchlist
Select watchlists to add or remove KYNB